Nuformix PLC

NFX

Company Profile

  • Business description

    Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

  • Contact

    60 Gracechurch Street
    6th Floor
    LondonEC3V 0HR
    GBR

    T: +44 1223627222

    E: [email protected]

    https://www.nuformix.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 September 2025

    Employees

    3

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,133.106.200.08%
CAC 407,807.0069.36-0.88%
DAX 4022,186.10353.88-1.57%
Dow JONES (US)41,989.9611.80-0.03%
FTSE 1008,577.2257.58-0.67%
HKSE23,202.534.31-0.02%
NASDAQ17,449.89150.600.87%
Nikkei 22535,725.87101.390.28%
NZX 50 Index12,320.197.590.06%
S&P 5005,633.070.000.00%
S&P/ASX 2007,934.509.300.12%
SSE Composite Index3,350.131.690.05%

Market Movers